4D Molecular Therapeutics (FDMT) Q2 2025 Earnings

8MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.89
-0.8
-0.72
-0.63

Details

Expected EPS
-0.87076
Actual EPS
-0.86
Surprise EPS
0.01
Surprise Percent
+1.24%

Description

4D Molecular Therapeutics (FDMT) has reported earnings of -0.86 per share for Q2 2025.

0 Comments

Share your thoughts